Cargando…
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)
BACKGROUND: Infectious complications are a significant cause of morbidity and mortality in patients undergoing allogeneic haematopoietic stem cell transplantation (Allo-SCT). The BATMO (Best-Antimicrobial-Therapy-TMO) is an innovative program for infection prevention and management and has been used...
Autores principales: | Malagola, Michele, Turra, Alessandro, Signorini, Liana, Corbellini, Silvia, Polverelli, Nicola, Masina, Lorenzo, Del Fabro, Giovanni, Lorenzotti, Silvia, Fumarola, Benedetta, Farina, Mirko, Morello, Enrico, Radici, Vera, Buttini, Eugenia Accorsi, Colnaghi, Federica, Bernardi, Simona, Re, Federica, Caruso, Arnaldo, Castelli, Francesco, Russo, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247274/ https://www.ncbi.nlm.nih.gov/pubmed/35785189 http://dx.doi.org/10.3389/fonc.2022.874117 |
Ejemplares similares
-
High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review
por: Accorsi Buttini, Eugenia, et al.
Publicado: (2023) -
Advances in CMV Management: A Single Center Real-Life Experience
por: Malagola, Michele, et al.
Publicado: (2020) -
Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia
por: Malagola, Michele, et al.
Publicado: (2023) -
Feasibility of tumor-derived exosome enrichment in the onco-hematology leukemic model of chronic myeloid leukemia
por: Bernardi, Simona, et al.
Publicado: (2019) -
PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA
por: Accorsi Buttini, E., et al.
Publicado: (2022)